ITP
MCID: THR100
MIFTS: 65

Thrombocytopenic Purpura, Autoimmune (ITP)

Categories: Blood diseases, Bone diseases, Immune diseases, Rare diseases

Aliases & Classifications for Thrombocytopenic Purpura, Autoimmune

MalaCards integrated aliases for Thrombocytopenic Purpura, Autoimmune:

Name: Thrombocytopenic Purpura, Autoimmune 57 76 59 13
Idiopathic Thrombocytopenic Purpura 57 12 76 53 15 40
Immune Thrombocytopenic Purpura 57 12 59 73
Autoimmune Thrombocytopenic Purpura 12 53 15
Itp 57 53 59
Thrombocytopenia Due to Platelet Alloimmunization 73
Purpura, Thrombocytopenic, Idiopathic 44
Immune Thrombocytopenic Purpura; Itp 57
Thrombocytopenic Purpura Autoimmune 53
Purpura Thrombocytopenic Idiopathic 55
Primary Thrombocytopenic Purpura 12
Ideopath Thrombocytopenic Pur 12
Autoimmune Thrombocytopenia 73
Immune Thrombocytopenia 59
Idiopathic Purpura 12
Werlhof's Disease 12
Aitp 57

Characteristics:

Orphanet epidemiological data:

59
immune thrombocytopenic purpura
Inheritance: Not applicable; Prevalence: 1-5/10000 (Europe),1-9/100000 (France); Age of onset: All ages;

OMIM:

57
Inheritance:
autosomal dominant form


HPO:

32
thrombocytopenic purpura, autoimmune:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 57 188030
Disease Ontology 12 DOID:8924
ICD10 33 D69.3
ICD9CM 35 287.31
MeSH 44 D016553
NCIt 50 C3446
SNOMED-CT 68 13172003 32273002
Orphanet 59 ORPHA3002
MESH via Orphanet 45 D016553
UMLS via Orphanet 74 C0398650
ICD10 via Orphanet 34 D69.3
MedGen 42 C0398650

Summaries for Thrombocytopenic Purpura, Autoimmune

NIH Rare Diseases : 53 Idiopathic thrombocytopenic purpura (ITP) is a bleeding disorder characterized by too few platelets in the blood. This is because platelets are being destroyed by the immune system. Symptoms may include bruising, nosebleed or bleeding in the mouth, bleeding into the skin, and abnormally heavy menstruation. With treatment, the chance of remission (a symptom-free period) is good. Rarely, ITP may become a chronic ailment in adults and reappear, even after remission.

MalaCards based summary : Thrombocytopenic Purpura, Autoimmune, also known as idiopathic thrombocytopenic purpura, is related to amegakaryocytic thrombocytopenia, congenital and thrombocytopenia due to platelet alloimmunization. An important gene associated with Thrombocytopenic Purpura, Autoimmune is FCGR2C (Fc Fragment Of IgG Receptor IIc (Gene/Pseudogene)), and among its related pathways/superpathways are TGF-Beta Pathway and Cytokine Signaling in Immune system. The drugs Dexamethasone acetate and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and t cells, and related phenotypes are thromboembolism and thrombocytopenia

Disease Ontology : 12 A primary thrombocytopenia that involves relatively few platelets in blood as a result of autoantibodies.

Genetics Home Reference : 25 Immune thrombocytopenia is a disorder characterized by a blood abnormality called thrombocytopenia, which is a shortage of blood cell fragments called platelets that are needed for normal blood clotting.

OMIM : 57 Autoimmune thrombocytopenic purpura is characterized by a low platelet count, normal bone marrow, and the absence of other causes of thrombocytopenia. It is principally a disorder of increased platelet destruction mediated by autoantibodies to platelet-membrane antigens (George et al., 1994). (188030)

Wikipedia : 76 Immune thrombocytopenia (ITP) is a type of thrombocytopenic purpura defined as isolated low platelet... more...

Related Diseases for Thrombocytopenic Purpura, Autoimmune

Diseases related to Thrombocytopenic Purpura, Autoimmune via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 435)
# Related Disease Score Top Affiliating Genes
1 amegakaryocytic thrombocytopenia, congenital 31.9 THPO MPL
2 thrombocytopenia due to platelet alloimmunization 31.8 THPO SELP MPL ITGB3 ITGA2B FCGR2C
3 purpura 30.8 THPO MPL ITGB3 ITGA2B
4 thrombosis 30.2 SELP GP6 GP1BA
5 myelodysplastic syndrome 30.1 THPO MPL IL11 DNMT3B
6 polycythemia vera 30.1 ITGB3 MPL SELP THPO
7 splenomegaly 30.0 MPL IFNA2
8 thrombasthenia 30.0 SELP ITGB3 ITGA2B GP1BA
9 clopidogrel resistance 29.9 SELP ITGB3
10 myelofibrosis 29.9 THPO MPL IFNA2
11 thrombocytosis 29.9 THPO SELP MPL IL11
12 bernard-soulier syndrome 29.8 THPO ITGB3 ITGA2B GP1BA
13 thrombocytopenia 29.7 THPO MPL ITGB3 ITGA2B IL11 GP1BA
14 thrombocytopenia-absent radius syndrome 29.7 GP1BA MPL THPO
15 coronary thrombosis 29.6 GP1BA GP6 ITGB3
16 myocardial infarction 29.6 SELP ITGB3 ITGA2B GP6 GP1BA
17 leukemia, chronic myeloid 29.6 THPO MPL IFNA2
18 blood platelet disease 29.4 THPO SELP MPL ITGB3 ITGA2B GP1BA
19 aplastic anemia 29.4 MPL ITGA2B IL11 GATA3 THPO
20 essential thrombocythemia 29.1 THPO SELP MPL ITGB3 ITGA2B IL11
21 thrombotic thrombocytopenic purpura, acquired 11.8
22 sea-blue histiocyte disease 11.7
23 immunodeficiency, common variable, 8, with autoimmunity 11.5
24 ras-associated autoimmune leukoproliferative disorder 11.4
25 spondyloenchondrodysplasia 11.3
26 purine nucleoside phosphorylase deficiency 11.0
27 inosine triphosphatase deficiency 11.0
28 antiphospholipid syndrome, familial 11.0
29 hepatitis 10.4
30 anemia, autoimmune hemolytic 10.3
31 colitis 10.2
32 thrombocytopenia 3 10.2 THPO MPL
33 thrombocythemia 1 10.2 THPO MPL
34 hemolytic anemia 10.2
35 dyskeratosis congenita, autosomal dominant 6 10.2 THPO MPL
36 stroke, ischemic 10.2
37 ulcerative colitis 10.2
38 nocardiosis 10.2
39 helicobacter pylori infection 10.2
40 common variable immunodeficiency 10.2
41 rabies 10.2
42 hepatitis c 10.2
43 viral infectious disease 10.2
44 cytomegalovirus infection 10.2
45 carotid artery thrombosis 10.2 SELP ITGA2B
46 bleeding disorder, platelet-type, 16 10.2 ITGB3 ITGA2B
47 leukocyte adhesion deficiency, type iii 10.1 SELP ITGA2B
48 breast cancer 10.1
49 multiple sclerosis 10.1
50 renal cell carcinoma, nonpapillary 10.1

Graphical network of the top 20 diseases related to Thrombocytopenic Purpura, Autoimmune:



Diseases related to Thrombocytopenic Purpura, Autoimmune

Symptoms & Phenotypes for Thrombocytopenic Purpura, Autoimmune

Symptoms via clinical synopsis from OMIM:

57
Heme:
thrombocytopenia
bleeding diathesis

Lab:
platelet antibody


Clinical features from OMIM:

188030

Human phenotypes related to Thrombocytopenic Purpura, Autoimmune:

59 32 (show all 12)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 thromboembolism 59 32 hallmark (90%) Very frequent (99-80%) HP:0001907
2 thrombocytopenia 59 32 hallmark (90%) Very frequent (99-80%) HP:0001873
3 gastrointestinal hemorrhage 59 32 occasional (7.5%) Occasional (29-5%) HP:0002239
4 epistaxis 59 32 occasional (7.5%) Occasional (29-5%) HP:0000421
5 bruising susceptibility 59 32 occasional (7.5%) Occasional (29-5%) HP:0000978
6 gingival bleeding 59 32 occasional (7.5%) Occasional (29-5%) HP:0000225
7 petechiae 59 32 frequent (33%) Frequent (79-30%) HP:0000967
8 arterial thrombosis 59 32 frequent (33%) Frequent (79-30%) HP:0004420
9 cerebral hemorrhage 59 32 very rare (1%) Very rare (<4-1%) HP:0001342
10 abnormal bleeding 32 HP:0001892
11 purpura 59 Frequent (79-30%)
12 platelet antibody positive 32 HP:0003454

GenomeRNAi Phenotypes related to Thrombocytopenic Purpura, Autoimmune according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased human papilloma virus 16 (HPV16) pseudovirus infection GR00306-A 9.02 DNMT3B GATA3 GP6 IL18 ITGA2B

MGI Mouse Phenotypes related to Thrombocytopenic Purpura, Autoimmune:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.9 DNMT3B GATA3 GP1BA GP6 IL18 ITGA2B
2 immune system MP:0005387 9.65 DNMT3B GATA3 GP6 IL18 ITGA2B ITGB3
3 vision/eye MP:0005391 9.1 DNMT3B GATA3 GP6 IL18 ITGB3 SELP

Drugs & Therapeutics for Thrombocytopenic Purpura, Autoimmune

Drugs for Thrombocytopenic Purpura, Autoimmune (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 956)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 1177-87-3
2
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-02-2 5743
3
Artesunate Approved, Investigational Phase 4,Not Applicable 88495-63-0 5464098 6917864
4
Artemether Approved Phase 4,Phase 3 71963-77-4 119380 68911
5
Mefloquine Approved, Investigational Phase 4 53230-10-7 4046
6
Lumefantrine Approved Phase 4,Phase 3 82186-77-4 6437380
7
Amodiaquine Approved, Investigational Phase 4 86-42-0 2165
8
Alfentanil Approved, Illicit Phase 4 71195-58-9 51263
9
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 2921-57-5
10
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 83-43-2 6741
11
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-24-8 5755
12
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 302-25-0
13
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2 50-28-2 5757
14
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
15
Polyestradiol phosphate Approved Phase 4,Phase 2 28014-46-2
16
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
17
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
18 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 2 979-32-8
19
Sulfadoxine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 2447-57-6 17134
20
Pyrimethamine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 58-14-0 4993
21
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58-05-9 6006 143
22
Ondansetron Approved Phase 4 99614-02-5 4595
23
Tetracaine Approved, Vet_approved Phase 4 94-24-6 5411
24
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
25
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
26
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
27
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3 148553-50-8 5486971
28
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 57-22-7, 2068-78-2 5978
29
Clarithromycin Approved Phase 4,Phase 2,Phase 3,Phase 1 81103-11-9 84029
30
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
31
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3 26787-78-0 33613
32
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
33
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
34
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53-03-2 5865
35
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772 46507594
36
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6
37
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-61-6, 62-31-7 681
38
Methamphetamine Approved, Illicit Phase 4,Phase 2,Phase 1,Not Applicable 537-46-2 10836
39
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53123-88-9 46835353 6436030 5284616
40
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
41
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 159351-69-6 6442177
42
Adalimumab Approved Phase 4,Phase 3 331731-18-1 16219006
43
Azathioprine Approved Phase 4,Phase 3,Not Applicable 446-86-6 2265
44
Hydroxychloroquine Approved Phase 4 118-42-3 3652
45
Dinoprostone Approved Phase 4 363-24-6 5280360
46
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
47
Nepafenac Approved, Investigational Phase 4 78281-72-8 151075
48
Ezetimibe Approved Phase 4 163222-33-1 150311
49
Simvastatin Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 79902-63-9 54454
50
Citalopram Approved Phase 4,Phase 3,Phase 2 59729-33-8 2771

Interventional clinical trials:

(show top 50) (show all 1580)
# Name Status NCT ID Phase Drugs
1 Caffeic Acid Combining High-dose Dexamethasone in Management of ITP Unknown status NCT02556814 Phase 4 Caffeic acid tablets;Dexamethasone;placebo
2 Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria Unknown status NCT00902811 Phase 4 AM(FDC);AM(LT);AL;DP;AA(FDC)
3 Pain Evaluation During Follicle Aspiration: Comparison of Two Sedation Protocols Unknown status NCT00742807 Phase 4 Low dose of alfentanil hydrochloride;Normal dose of alfentanil hydrochloride
4 Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis Unknown status NCT00265772 Phase 4 MODULEN IBD (R) (specific Enteral Nutrition);prednisolon
5 Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification Unknown status NCT01296191 Phase 4 Moxifloxacin;besifloxacin
6 Graz Study on the Risk of Atrial Fibrillation Unknown status NCT01461434 Phase 4
7 Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT Unknown status NCT01379391 Phase 4 Recombinant Human Thrombopoietin (rHTPO)
8 A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques Unknown status NCT02532309 Phase 4 Rosuvastatin (5mg,10mg,20mg);Rosuvastatin 5mg
9 tDCS as Add on Therapy for Treatment of Tobacco Dependence by Standardized Behaviour Therapy Unknown status NCT01729507 Phase 4
10 Intermittent Antimalaria Treatment With SP in African Children Unknown status NCT00168948 Phase 4 Sulfadoxin (12.5) Pyrimethamine (250 mg)
11 Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate Unknown status NCT00238017 Phase 4 amodiaquine-artesunate versus amodiaquine
12 Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery Unknown status NCT02085551 Phase 4
13 Neurobiological and Cognitive Changes Following Exposure to Either Sevoflurane- or Propofol-based Anesthesia in Children Unknown status NCT03022240 Phase 4 Propofol;Sevoflurane;Ametop;Ondansetron
14 Effects of Pregabalin on Mechanical Hyperalgesia Unknown status NCT00310583 Phase 4 Pregabalin
15 Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia Completed NCT03229746 Phase 4 Hydroxychloroquine;vincristine;azathioprine
16 Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura Completed NCT00467571 Phase 4 lansoprazole, clarithromycin, amoxycillin
17 A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) Completed NCT01390649 Phase 4
18 Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag Completed NCT00888901 Phase 4 eltrombopag;corticosteroids (Aprednislon)
19 The Study of Different Dose Rituximab in the Treatment of ITP Completed NCT03258866 Phase 4 Rituximab;Rituximab
20 Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) Completed NCT00907478 Phase 4
21 High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) Completed NCT01356511 Phase 4 Prednisone;Dexamethasone
22 A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification Completed NCT01021761 Phase 4 Ketorolac Tromethamine;Bromfenac;nepafenac
23 A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification Completed NCT01001806 Phase 4 Ketorolac Tromethamine 0.45%;bromfenac 0.09%;nepafenac 0.1%
24 The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study Completed NCT00817843 Phase 4 Simvastatin;Simvastatin/Ezetimibe
25 Comparison of Rotating vs. Fixed Platform of the COLUMBUS Knee Prosthesis Completed NCT00822640 Phase 4
26 Treatment of Depression in Adults Completed NCT00073697 Phase 4 Escitalopram
27 Raltegravir Kaletra Pharmacokinetics Completed NCT00564772 Phase 4 Raltegravir, lopinavir, ritonavir
28 Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects Completed NCT00469690 Phase 4 Acular, Xibrom
29 Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease Completed NCT00534651 Phase 4 Paracetamol
30 A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID) Completed NCT01023724 Phase 4 Ketorolac Tromethamine 0.45%;Bromfenac 0.09%
31 Effect of Thiazolidinedione Treatment Vascular Risk Markers Completed NCT00571506 Phase 4 Rosiglitazone;Pioglitazone
32 Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl Completed NCT00533559 Phase 4 sodium phenylbutyrate;Placebo
33 Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion Completed NCT00188773 Phase 4 N-acetylcysteine, intralipid, heparin
34 Moxifloxacin vs. Polytrim for Conjunctivitis Completed NCT00581542 Phase 4 moxifloxacin;polytrim
35 Mechanism of Growth Hormone Effects on Adipose Tissue Completed NCT00453557 Phase 4 rhGH
36 "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM Completed NCT00402012 Phase 4 Pioglitazone
37 Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients Completed NCT00347503 Phase 4 ketorolac 0.4%, bromfenac 0.09%
38 Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder Completed NCT00178061 Phase 4
39 Oat Breakfast Satiety Study Completed NCT01372683 Phase 4
40 Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine Completed NCT00975325 Phase 4 Yohimbine;Yohimbine
41 Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy Completed NCT01170754 Phase 4 PEG-3350 and Gatorade;Golytely 4 liters
42 Psychosocial Therapy Plus Maintenance Pharmacotherapy for Treating Bipolar Disorder Completed NCT00227968 Phase 4
43 Comparing Various Treatments for Achieving and Maintaining Remission of Depression Completed NCT00227955 Phase 4 Imipramine
44 Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage Completed NCT01082302 Phase 4 Polyphenon E (Veregen) 15% ointment
45 Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil Completed NCT01363765 Phase 4
46 Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent? Completed NCT01091714 Phase 4
47 Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA) Completed NCT00094575 Phase 4
48 Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function Completed NCT00189085 Phase 4 simvastatin and ezetimibe
49 Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study Completed NCT00222820 Phase 4 escitalopram
50 Methamphetamine Abuse Treatment in Patients With AIDS - 1 Completed NCT00000321 Phase 4 Desipramine

Search NIH Clinical Center for Thrombocytopenic Purpura, Autoimmune

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: purpura, thrombocytopenic, idiopathic

Genetic Tests for Thrombocytopenic Purpura, Autoimmune

Anatomical Context for Thrombocytopenic Purpura, Autoimmune

MalaCards organs/tissues related to Thrombocytopenic Purpura, Autoimmune:

41
Bone, Bone Marrow, T Cells, Skin, B Cells, Spleen, Myeloid

Publications for Thrombocytopenic Purpura, Autoimmune

Articles related to Thrombocytopenic Purpura, Autoimmune:

(show top 50) (show all 1154)
# Title Authors Year
1
Idiopathic Thrombocytopenic Purpura Responsive to Surgery for Crohn's Disease. ( 29961815 )
2018
2
Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable. ( 29399856 )
2018
3
No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab. ( 29400292 )
2018
4
Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome. ( 29905024 )
2018
5
Idiopathic thrombocytopenic purpura in a patient with IgG4-related disease. ( 29888414 )
2018
6
Is Helicobacter pylori infection the potential link between interleukin-17 and idiopathic thrombocytopenic purpura? ( 29856194 )
2018
7
Disseminated herpes simplex virus and varicella zoster virus co-infection in a patient with idiopathic thrombocytopenic purpura. ( 30213467 )
2018
8
Concurrent Autoimmune Neutropenia and Idiopathic Thrombocytopenic Purpura Associated with IgG4-related Diease. ( 29491289 )
2018
9
The impact of helicobacter pylori eradication on platelet counts of adult patients with idiopathic thrombocytopenic purpura. ( 30250741 )
2018
10
Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials. ( 30402091 )
2018
11
Platelet count on preoperative day 1 predicts the long-term responses to laparoscopic splenectomy for Chinese patients with medically refractory idiopathic thrombocytopenic purpura. ( 30477462 )
2018
12
Idiopathic Thrombocytopenic Purpura Induced by Synthetic Cannabinoid. ( 30531235 )
2018
13
A Case of Multiple Cerebral Infarction Preceding Acute Exacerbation of Idiopathic Thrombocytopenic Purpura. ( 30553647 )
2018
14
The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study. ( 29297977 )
2018
15
Platelet count response to Helicobacter pylori eradication for idiopathic thrombocytopenic purpura in northeastern Brazil. ( 29519366 )
2018
16
Hyperheptaploidy in idiopathic thrombocytopenic purpura. ( 29567917 )
2018
17
Bilateral visual loss and cerebral infarction after spleen embolization in a trauma patient with idiopathic thrombocytopenic purpura: A case report. ( 29668582 )
2018
18
High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm Trial. ( 29674771 )
2018
19
Hypogammaglobulinemia Observed One Year after Rituximab Treatment for Idiopathic Thrombocytopenic Purpura. ( 29755528 )
2018
20
Successful Treatment of Idiopathic Thrombocytopenic Purpura After Liver Transplant: A Case Report. ( 30066626 )
2018
21
Systemic lupus erythematosus, following prodromal idiopathic thrombocytopenic purpura, presenting with skin lesions resembling malignant atrophic papulosis. ( 28691162 )
2017
22
Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection. ( 29085203 )
2017
23
Intravenous Immunoglobulin-Induced Profound Bradycardia in a Patient With Idiopathic Thrombocytopenic Purpura. ( 28930759 )
2017
24
Idiopathic thrombocytopenic purpura in childhood, Langerhans cell histiocytosis in adulthood: More than a chance association? ( 28255140 )
2017
25
Idiopathic thrombocytopenic purpura and autoimmune neutropenia induced by prolonged use of nivolumab in Hodgkin's lymphoma. ( 28379290 )
2017
26
An idiopathic thrombocytopenic purpura with polyneuropathy. ( 27427299 )
2017
27
The Effective Treatment with Cyclosporine of a Ulcerative Colitis Patient with Concurrent Idiopathic Thrombocytopenic Purpura Who Subsequently Developed Spontaneous Pneumomediastinum. ( 28566594 )
2017
28
Idiopathic thrombocytopenic purpura: pathogenesis and potential therapeutic approach. ( 28643502 )
2017
29
Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients. ( 28654425 )
2017
30
Patterns of care and burden of chronic idiopathic thrombocytopenic purpura in Brazil. ( 28673116 )
2017
31
Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders). ( 28689597 )
2017
32
Vertebral Artery Thrombosis in Chronic Idiopathic Thrombocytopenic Purpura. ( 28695024 )
2017
33
Effectiveness of Helicobacter pylori eradication in pregnant women with idiopathic thrombocytopenic purpura. ( 28718212 )
2017
34
Idiopathic Thrombocytopenic Purpura in Individuals Older than 75 Years: A Rare Series. ( 28863226 )
2017
35
Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone. ( 29173312 )
2017
36
Spontaneous retrobulbar haemorrhage in idiopathic thrombocytopenic purpura. ( 29237670 )
2017
37
Paradoxical thrombosis in idiopathic thrombocytopenic purpura. ( 27771836 )
2017
38
Case of twin pregnancy complicated by idiopathic thrombocytopenic purpura treated with intravenous immunoglobulin: Review of the literature. ( 27958258 )
2017
39
Multiple and recurrent cerebral infarctions in a patient with idiopathic thrombocytopenic purpura. ( 28351532 )
2017
40
Analysis of clinical effects and mechanism of recombinant human interleukin-11 with glucocorticoids for treatment of idiopathic thrombocytopenic purpura. ( 28352325 )
2017
41
Submucosal esophageal hematoma precipitated by chronic idiopathic thrombocytopenic purpura. ( 28491169 )
2017
42
Aortic Root Rupture during Transcatheter Aortic Valve Implantation in a Patient with Idiopathic Thrombocytopenic Purpura: Utility of Transesophageal Echocardiography in Early Detection and Description of a Semiconservative Surgical Management Approach. ( 28031654 )
2016
43
CD16 and CD32 Gene Polymorphisms May Contribute to Risk of Idiopathic Thrombocytopenic Purpura. ( 27315784 )
2016
44
A case of congenital prothrombin deficiency and idiopathic thrombocytopenic purpura in a pregnant female. ( 26886363 )
2016
45
Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura. ( 27211045 )
2016
46
Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. ( 26984073 )
2016
47
Multiple cerebral infarctions in a patient with idiopathic thrombocytopenic purpura. ( 27648181 )
2016
48
Idiopathic Thrombocytopenic Purpura Masquerading Pediatric Systemic Lupus Erythematosus. ( 27057049 )
2016
49
Predictive Factors of Idiopathic Thrombocytopenic Purpura and Long-term Survival in Chinese Adults Undergoing Laparoscopic Splenectomy. ( 27749769 )
2016
50
Impact of serum immunoglobulins level and IL-18 promoter gene polymorphism among Egyptian patients with idiopathic thrombocytopenic purpura. ( 27600402 )
2016

Variations for Thrombocytopenic Purpura, Autoimmune

Copy number variations for Thrombocytopenic Purpura, Autoimmune from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 21699 1 160500000 165500000 Copy number FCGR2C Idiopathic thrombocytopenic purpura
2 46119 10 77700000 82000000 Copy number BMPR1A Idiopathic thrombocytopenic purpura
3 121460 18 43500000 48200000 Copy number MADH4 Idiopathic thrombocytopenic purpura

Expression for Thrombocytopenic Purpura, Autoimmune

Search GEO for disease gene expression data for Thrombocytopenic Purpura, Autoimmune.

Pathways for Thrombocytopenic Purpura, Autoimmune

Pathways related to Thrombocytopenic Purpura, Autoimmune according to GeneCards Suite gene sharing:

(show all 19)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.28 IFNA2 IL11 IL18 ITGA2B ITGB3 MPL
2
Show member pathways
13.11 GATA3 IFNA2 IL11 IL18 ITGA2B ITGB3
3
Show member pathways
12.99 GATA3 GP1BA GP6 IFNA2 ITGA2B ITGB3
4
Show member pathways
12.14 IFNA2 IL11 MPL THPO
5
Show member pathways
12 GP6 ITGB3 SELP
6 11.99 FCGR2C IFNA2 IL18
7
Show member pathways
11.85 GP1BA GP6 ITGA2B ITGB3
8 11.71 GP1BA GP6 ITGA2B ITGB3
9
Show member pathways
11.54 GP1BA ITGA2B ITGB3 MPL THPO
10 11.46 FCGR2C IL18 ITGB3
11 11.34 GP1BA IL11 ITGA2B ITGB3 THPO
12 11.29 GP6 ITGA2B ITGB3
13 11.23 GP1BA IFNA2 IL11 ITGA2B ITGB3 MPL
14 11.12 ITGA2B ITGB3
15 11.08 GATA3 IL18
16 10.98 ITGA2B ITGB3
17 10.86 ITGA2B ITGB3
18 10.76 IL11 IL18 ITGA2B ITGB3 THPO
19 10.62 GP1BA GP6

GO Terms for Thrombocytopenic Purpura, Autoimmune

Cellular components related to Thrombocytopenic Purpura, Autoimmune according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.35 GP1BA GP6 ITGA2B ITGB3 MPL
2 integrin complex GO:0008305 9.16 ITGA2B ITGB3
3 platelet alpha granule membrane GO:0031092 8.8 ITGA2B ITGB3 SELP

Biological processes related to Thrombocytopenic Purpura, Autoimmune according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.73 IFNA2 IL11 IL18 THPO
2 leukocyte migration GO:0050900 9.65 GP6 ITGB3 SELP
3 positive regulation of protein kinase B signaling GO:0051897 9.63 GATA3 IL18 THPO
4 platelet degranulation GO:0002576 9.58 ITGA2B ITGB3 SELP
5 cytokine-mediated signaling pathway GO:0019221 9.55 GATA3 IFNA2 IL11 IL18 MPL
6 platelet activation GO:0030168 9.54 GP1BA GP6 ITGB3
7 blood coagulation GO:0007596 9.35 GATA3 GP1BA GP6 IFNA2 ITGB3
8 positive regulation of leukocyte migration GO:0002687 9.32 ITGA2B SELP
9 thrombopoietin-mediated signaling pathway GO:0038163 9.26 MPL THPO
10 platelet aggregation GO:0070527 8.92 GP1BA ITGA2B ITGB3 MPL

Molecular functions related to Thrombocytopenic Purpura, Autoimmune according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.26 IFNA2 IL11 IL18 THPO
2 extracellular matrix binding GO:0050840 9.16 ITGA2B ITGB3
3 fibrinogen binding GO:0070051 8.62 ITGA2B ITGB3

Sources for Thrombocytopenic Purpura, Autoimmune

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....